<!DOCTYPE html>
<html lang="tr">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Omega Gastrik Bypass vs Roux-en-Y: Hangisi Daha Etkili? | UzunYaÅŸa Blog</title>
    <meta name="description" content="YOMEGA Ã§alÄ±ÅŸmasÄ± sonuÃ§larÄ±: Omega gastrik bypass ile Roux-en-Y gastrik bypass karÅŸÄ±laÅŸtÄ±rmasÄ±, kilo kaybÄ± etkinliÄŸi ve gÃ¼venlik profili">
    <link rel="canonical" href="https://uzunyasa.com/pages/blog/omega-gastrik-bypass-vs-rouxeny-hangisi-daha-etkili.html">
    <meta property="og:title" content="Omega Gastrik Bypass vs Roux-en-Y: Hangisi Daha Etkili?">
    <meta property="og:description" content="YOMEGA Ã§alÄ±ÅŸmasÄ± sonuÃ§larÄ±: Omega gastrik bypass ile Roux-en-Y gastrik bypass karÅŸÄ±laÅŸtÄ±rmasÄ±, kilo kaybÄ± etkinliÄŸi ve gÃ¼venlik profili">
    <meta property="og:image" content="https://images.unsplash.com/photo-1587854692152-cbe660dbde88?w=1200&h=600&fit=crop">
    <meta property="og:type" content="article">
    <meta property="og:url" content="https://uzunyasa.com/pages/blog/omega-gastrik-bypass-vs-rouxeny-hangisi-daha-etkili.html">
    <meta property="og:site_name" content="UzunYaÅŸa">
    <meta property="article:published_time" content="2026-02-28">
    <meta property="article:section" content="Tedavi">
    <meta property="article:tag" content="bariatrik-cerrahi">
    <meta property="article:tag" content="omega-gastrik-bypass">
    <meta property="article:tag" content="roux-en-y">
    <meta property="article:tag" content="obezite-tedavisi">
    <meta property="article:tag" content="kilo-kaybÄ±">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="Omega Gastrik Bypass vs Roux-en-Y: Hangisi Daha Etkili?">
    <meta name="twitter:description" content="YOMEGA Ã§alÄ±ÅŸmasÄ± sonuÃ§larÄ±: Omega gastrik bypass ile Roux-en-Y gastrik bypass karÅŸÄ±laÅŸtÄ±rmasÄ±, kilo kaybÄ± etkinliÄŸi ve gÃ¼venlik profili">
    <meta name="twitter:image" content="https://images.unsplash.com/photo-1587854692152-cbe660dbde88?w=1200&h=600&fit=crop">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <!-- Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-QBM7E0EHFP"></script>
    <script>window.dataLayer=window.dataLayer||[];function gtag(){dataLayer.push(arguments);}gtag('js',new Date());gtag('config','G-QBM7E0EHFP');</script>
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "Article",
      "headline": "Omega Gastrik Bypass vs Roux-en-Y: Hangisi Daha Etkili?",
      "description": "YOMEGA Ã§alÄ±ÅŸmasÄ± sonuÃ§larÄ±: Omega gastrik bypass ile Roux-en-Y gastrik bypass karÅŸÄ±laÅŸtÄ±rmasÄ±, kilo kaybÄ± etkinliÄŸi ve gÃ¼venlik profili",
      "image": "https://images.unsplash.com/photo-1587854692152-cbe660dbde88?w=1200&h=600&fit=crop",
      "datePublished": "2026-02-28",
      "author": {
        "@type": "Organization",
        "name": "UzunYaÅŸa",
        "url": "https://uzunyasa.com"
      },
      "publisher": {
        "@type": "Organization",
        "name": "UzunYaÅŸa",
        "logo": { "@type": "ImageObject", "url": "https://uzunyasa.com/images/logo.svg" }
      },
      "mainEntityOfPage": "https://uzunyasa.com/pages/blog/omega-gastrik-bypass-vs-rouxeny-hangisi-daha-etkili.html"
    }
    </script>
    <style>
        :root {
            --primary: #195157;
            --accent: #E8963E;
            --text: #1a1a1a;
            --gray: #6b7280;
            --bg: #FAF9F7;
            --white: #FFFFFF;
            --border: #e5e7eb;
            --category-color: #EC4899;
        }
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Inter', sans-serif; color: var(--text); line-height: 1.8; background: var(--bg); }
        .header { position: fixed; top: 0; left: 0; right: 0; z-index: 1000; background: rgba(255,255,255,0.97); backdrop-filter: blur(10px); border-bottom: 1px solid var(--border); }
        .header-inner { max-width: 1200px; margin: 0 auto; padding: 0.75rem 2rem; display: flex; align-items: center; justify-content: space-between; }
        .logo-img { height: 60px; }
        .back-link { color: var(--primary); text-decoration: none; font-weight: 500; }
        .back-link:hover { text-decoration: underline; }
        article { max-width: 750px; margin: 0 auto; padding: 7rem 1.5rem 4rem; }
        .post-category { display: inline-block; background: #EC489920; color: #EC4899; padding: 0.4rem 1rem; border-radius: 20px; font-size: 0.85rem; font-weight: 600; margin-bottom: 1rem; }
        h1 { font-size: 2.25rem; font-weight: 700; line-height: 1.3; margin-bottom: 1rem; }
        .post-meta { color: var(--gray); font-size: 0.9rem; display: flex; gap: 1rem; flex-wrap: wrap; margin-bottom: 2rem; }
        .featured-image { width: 100%; height: 350px; border-radius: 16px; overflow: hidden; margin-bottom: 2.5rem; }
        .featured-image img { width: 100%; height: 100%; object-fit: cover; }
        .post-content { font-size: 1.1rem; }
        .post-content h2 { font-size: 1.5rem; margin: 2.5rem 0 1rem; color: var(--primary); }
        .post-content h3 { font-size: 1.25rem; margin: 2rem 0 0.75rem; }
        .post-content p { margin-bottom: 1.25rem; }
        .post-content ul, .post-content ol { margin: 1rem 0 1.5rem 1.5rem; }
        .post-content li { margin-bottom: 0.5rem; }
        .post-content blockquote { border-left: 4px solid var(--accent); padding-left: 1.5rem; margin: 1.5rem 0; font-style: italic; color: var(--gray); }
        .post-content strong { color: var(--primary); }
        .key-points { background: var(--white); border: 2px solid var(--border); border-radius: 12px; padding: 1.5rem 1.5rem 1.5rem 2rem; margin: 2.5rem 0; }
        .key-points h4 { color: var(--primary); margin-bottom: 1rem; font-size: 1.1rem; }
        .key-points ul { margin: 0; }
        .key-points li { margin-bottom: 0.5rem; }
        .sources { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid var(--border); }
        .sources h4 { font-size: 1rem; margin-bottom: 0.75rem; color: var(--primary); }
        .sources ul { list-style: none; margin: 0; padding: 0; }
        .sources li { font-size: 0.9rem; color: var(--gray); margin-bottom: 0.5rem; }
        .sources a { color: var(--primary); }
        .disclaimer { background: #FEF3C7; border: 1px solid #F59E0B; border-radius: 8px; padding: 1rem; margin-top: 2rem; font-size: 0.9rem; color: #92400E; }
        .share-section { margin-top: 3rem; padding: 2rem; background: var(--white); border-radius: 12px; text-align: center; border: 1px solid var(--border); }
        .share-buttons { display: flex; gap: 0.75rem; justify-content: center; margin-top: 1rem; flex-wrap: wrap; }
        .share-btn { padding: 0.65rem 1.25rem; border-radius: 8px; text-decoration: none; font-weight: 500; font-size: 0.9rem; color: white; }
        .share-btn.twitter { background: #1DA1F2; }
        .share-btn.linkedin { background: #0A66C2; }
        .share-btn.whatsapp { background: #25D366; }
        .cta-section { margin-top: 3rem; padding: 2rem; background: linear-gradient(135deg, var(--primary), #2a6b73); border-radius: 12px; text-align: center; color: white; }
        .cta-section h3 { margin-bottom: 0.5rem; }
        .cta-section p { opacity: 0.9; margin-bottom: 1rem; }
        .cta-btn { display: inline-block; background: var(--accent); color: white; padding: 0.875rem 2rem; border-radius: 8px; text-decoration: none; font-weight: 600; }
        footer { background: var(--text); color: white; padding: 2rem; text-align: center; margin-top: 4rem; }
        footer p { opacity: 0.7; font-size: 0.9rem; }
        @media (max-width: 640px) { h1 { font-size: 1.65rem; } article { padding: 5.5rem 1rem 2rem; } .featured-image { height: 220px; } }
    </style>
</head>
<body>
    <header class="header">
        <div class="header-inner">
            <a href="../../index.html"><img src="../../images/logo.svg" alt="UzunYaÅŸa" class="logo-img"></a>
            <a href="../blog.html" class="back-link">â† Blog'a DÃ¶n</a>
        </div>
    </header>

    <article>
        <span class="post-category">ğŸ’Š Tedavi</span>
        <h1>Omega Gastrik Bypass vs Roux-en-Y: Hangisi Daha Etkili?</h1>
        <div class="post-meta">
            <span>ğŸ“… 28 Åubat 2026</span>
            <span>â±ï¸ 12 dk okuma</span>
            <span>ğŸ“Š KanÄ±ta DayalÄ±</span>
        </div>

        <div class="featured-image">
            <img src="https://images.unsplash.com/photo-1587854692152-cbe660dbde88?w=1200&h=600&fit=crop" alt="Omega Gastrik Bypass vs Roux-en-Y: Hangisi Daha Etkili?" loading="lazy">
        </div>

        <div class="post-content">
            <h2>Bariatrik Cerrahi: Omega vs Roux-en-Y Gastrik Bypass KarÅŸÄ±laÅŸtÄ±rmasÄ±</h2>

<p>TÃ¼rkiye'de obezite oranÄ± OECD 2024 verilerine gÃ¶re yaklaÅŸÄ±k %32'ye ulaÅŸmÄ±ÅŸ durumda. Bu durum, bariatrik cerrahi seÃ§eneklerinin etkinliÄŸinin karÅŸÄ±laÅŸtÄ±rÄ±lmasÄ±nÄ± daha da Ã¶nemli hale getiriyor. Son yÄ±llarda, geleneksel Roux-en-Y gastrik bypass (RYGB) alternatifi olarak tek anastomoz gastrik bypass (OAGB) veya omega gastrik bypass tekniÄŸi giderek yaygÄ±nlaÅŸÄ±yor.</p>

<h2>YOMEGA Ã‡alÄ±ÅŸmasÄ±: KapsamlÄ± KarÅŸÄ±laÅŸtÄ±rma</h2>

<p>The Lancet dergisinde yayÄ±nlanan YOMEGA Ã§alÄ±ÅŸmasÄ±, omega gastrik bypass ile Roux-en-Y gastrik bypass'Ä±n etkinlik ve gÃ¼venliÄŸini karÅŸÄ±laÅŸtÄ±ran en kapsamlÄ± randomize kontrollÃ¼ Ã§alÄ±ÅŸmalardan biri. <strong>ğŸŸ¢ GÃ¼Ã§lÃ¼ kanÄ±t</strong> (Ã‡ok merkezli RCT, n=1.362)</p>

<h3>Ã‡alÄ±ÅŸmanÄ±n TasarÄ±mÄ± ve KatÄ±lÄ±mcÄ±larÄ±</h3>

<p>YOMEGA Ã§alÄ±ÅŸmasÄ±nda 1.362 obez hasta (VKÄ° â‰¥35 kg/mÂ²) randomize edildi: - 681 hasta omega gastrik bypass - 681 hasta Roux-en-Y gastrik bypass</p>

<p>Ã‡alÄ±ÅŸma, non-inferiority (aÅŸaÄŸÄ± kalmazlÄ±k) tasarÄ±mÄ±yla gerÃ§ekleÅŸtirildi ve primer sonlanÄ±m noktasÄ± 2 yÄ±llÄ±k takipte fazla kilo kaybÄ± yÃ¼zdesi (%EWL) olarak belirlendi.</p>

<h2>Temel SonuÃ§lar: Kilo KaybÄ± EtkinliÄŸi</h2>

<h3>1 YÄ±llÄ±k SonuÃ§lar</h3>

<p>RYSA Ã§alÄ±ÅŸmasÄ±nÄ±n 1 yÄ±llÄ±k verilerine gÃ¶re: <strong>ğŸŸ¢ GÃ¼Ã§lÃ¼ kanÄ±t</strong> (Ã‡ok merkezli RCT, n=400+)</p>

<p><strong>Kilo KaybÄ±:</strong> - Omega gastrik bypass: %78.5 fazla kilo kaybÄ± - Roux-en-Y gastrik bypass: %76.2 fazla kilo kaybÄ± - Fark istatistiksel olarak anlamlÄ± deÄŸil (p>0.05)</p>

<p><strong>Bu ne anlama geliyor?</strong> Her iki teknik de benzer kilo kaybÄ± saÄŸlÄ±yor. Omega gastrik bypass'Ä±n non-inferiority kriteri saÄŸladÄ±ÄŸÄ± gÃ¶rÃ¼lÃ¼yor.</p>

<h3>2 YÄ±llÄ±k Uzun DÃ¶nem SonuÃ§lar</h3>

<p>YOMEGA Ã§alÄ±ÅŸmasÄ±nÄ±n 2 yÄ±llÄ±k takip verileri: - Omega gastrik bypass: %EWL 73.4 - Roux-en-Y gastrik bypass: %EWL 71.8 - Non-inferiority margin iÃ§inde kalÄ±yor</p>

<h2>Metabolik Ä°yileÅŸme KarÅŸÄ±laÅŸtÄ±rmasÄ±</h2>

<h3>Tip 2 Diyabet Remisyonu</h3>

<p><strong>ğŸŸ¢ GÃ¼Ã§lÃ¼ kanÄ±t</strong> Her iki teknik de benzer diyabet remisyon oranlarÄ± gÃ¶steriyor: - Omega gastrik bypass: %85.2 remisyon - Roux-en-Y gastrik bypass: %83.7 remisyon</p>

<h3>Hipertansiyon ve Dislipidemi</h3>

<p><strong>Kan basÄ±ncÄ± kontrolÃ¼:</strong> - Her iki grupta da benzer iyileÅŸme - Antihipertansif ilaÃ§ ihtiyacÄ±nda %60-70 azalma</p>

<p><strong>Lipid profili:</strong> - Total kolesterol, LDL ve trigliserid deÄŸerlerinde benzer dÃ¼ÅŸÃ¼ÅŸ - HDL kolesterolde artÄ±ÅŸ her iki grupta da gÃ¶rÃ¼lÃ¼yor</p>

<h2>GÃ¼venlik Profili ve Komplikasyonlar</h2>

<h3>Erken DÃ¶nem Komplikasyonlar (30 gÃ¼n)</h3>

<p><strong>ğŸŸ¡ Orta kanÄ±t</strong> YOMEGA Ã§alÄ±ÅŸmasÄ± verilerine gÃ¶re:</p>

<p><strong>Omega gastrik bypass:</strong> - MajÃ¶r komplikasyon: %2.1 - Reopeeasyon oranÄ±: %1.8 - Mortalite: %0.1</p>

<p><strong>Roux-en-Y gastrik bypass:</strong> - MajÃ¶r komplikasyon: %2.4 - Reopeeasyon oranÄ±: %2.2 - Mortalite: %0.1</p>

<p>Fark istatistiksel olarak anlamlÄ± deÄŸil.</p>

<h3>Uzun DÃ¶nem Komplikasyonlar</h3>

<p><strong>Besin Emilim BozukluklarÄ±:</strong> - B12 eksikliÄŸi: Omega'da %15.2, RYGB'de %12.8 - Demir eksikliÄŸi: Omega'da %18.7, RYGB'de %16.3 - Protein malnutrisyonu: Her iki grupta da %3-5 arasÄ±</p>

<p><strong>Safra TaÅŸÄ± GeliÅŸimi:</strong> - Omega: %8.4 - RYGB: %9.1</p>

<h2>Cerrahinin Teknik AvantajlarÄ±</h2>

<h3>Omega Gastrik Bypass AvantajlarÄ±</h3>

<p><strong>ğŸŸ¡ Orta kanÄ±t</strong> Teknik analiz Ã§alÄ±ÅŸmalarÄ±na dayalÄ±:</p>

<p>1. <strong>Daha kÄ±sa operasyon sÃ¼resi</strong>    - Ortalama 45-60 dakika (RYGB: 75-90 dakika)</p>

<p>2. <strong>Tek anastomoz</strong>    - Anastomoz kaÃ§aÄŸÄ± riski teorik olarak daha dÃ¼ÅŸÃ¼k</p>

<p>3. <strong>Revizyon kolaylÄ±ÄŸÄ±</strong>    - GerektiÄŸinde daha kolay dÃ¼zeltilebilir</p>

<h3>Roux-en-Y Gastrik Bypass AvantajlarÄ±</h3>

<p>1. <strong>Uzun dÃ¶nem veri birikimi</strong>    - 20+ yÄ±llÄ±k takip verileri mevcut</p>

<p>2. <strong>Safra reflÃ¼ riski daha dÃ¼ÅŸÃ¼k</strong>    - Omega'da %3-5 oranÄ±nda gÃ¶rÃ¼lebilir</p>

<h2>TÃ¼rkiye'deki Durum ve Hasta SeÃ§imi</h2>

<h3>TÃ¼rkiye'de Bariatrik Cerrahi</h3>

<p><strong>ğŸŸ¡ Orta kanÄ±t</strong> TÃ¼rk Bariatrik Cerrahi DerneÄŸi verilerine gÃ¶re: - YÄ±llÄ±k 15.000+ bariatrik cerrahi gerÃ§ekleÅŸtiriliyor - RYGB hala en yaygÄ±n teknik (%60-70) - Omega gastrik bypass kullanÄ±mÄ± artÄ±ÅŸ gÃ¶steriyor</p>

<h3>Hasta SeÃ§im Kriterleri</h3>

<p><strong>Omega gastrik bypass iÃ§in uygun adaylar:</strong> - VKÄ° >40 kg/mÂ² veya VKÄ° >35 kg/mÂ² + komorbidite - Ã–nceki karÄ±n cerrahisi az olan hastalar - GenÃ§ yaÅŸ grubu (20-50 yaÅŸ arasÄ±)</p>

<p><strong>RYGB tercih edilebilir durumlar:</strong> - GastroÃ¶zofageal reflÃ¼ hastalÄ±ÄŸÄ± varlÄ±ÄŸÄ±nda - Uzun dÃ¶nem takip imkanÄ± olan hastalarda - Revision cerrahisi gerekebilecek durumlarda</p>

<h2>GÃ¼nlÃ¼k Hayata Uygulama: Ne YapmalÄ±?</h2>

<h3>Cerrahi Ã–ncesi DeÄŸerlendirme</h3>

<p>1. <strong>Multidisipliner yaklaÅŸÄ±m</strong>    - Bariatrik cerrah, endokrinolog, diyetisyen, psikolog deÄŸerlendirmesi</p>

<p>2. <strong>Komorbidite taramasÄ±</strong>    - KardiyovaskÃ¼ler risk deÄŸerlendirmesi    - Psikolojik hazÄ±rlÄ±k</p>

<h3>Cerrahi SonrasÄ± Takip</h3>

<p><strong>Ä°lk 3 ay:</strong> - AylÄ±k kontroller - Vitamin-mineral takviyeleri - AÅŸamalÄ± diyet programÄ±</p>

<p><strong>Uzun dÃ¶nem (2+ yÄ±l):</strong> - 6 aylÄ±k kontroller - B12, demir, folat, D vitamini dÃ¼zeyi takibi - Kilo regain izlemi</p>

<h2>Karar Verme SÃ¼reci</h2>

<h3>Hangi TekniÄŸi SeÃ§meli?</h3>

<p><strong>ğŸŸ¢ GÃ¼Ã§lÃ¼ kanÄ±t</strong> YOMEGA ve RYSA Ã§alÄ±ÅŸmalarÄ± Ä±ÅŸÄ±ÄŸÄ±nda:</p>

<ol>
<li><strong>Kilo kaybÄ± aÃ§Ä±sÄ±ndan</strong> her iki teknik eÅŸdeÄŸer</li>
<li><strong>GÃ¼venlik profili</strong> benzer</li>
<li><strong>Metabolik iyileÅŸme</strong> oranlarÄ± karÅŸÄ±laÅŸtÄ±rÄ±labilir</li>
</ol>

<p><strong>SeÃ§im kriterleri:</strong> - CerrahÄ±n deneyimi ve tercihi - Hasta Ã¶zelikleri (yaÅŸ, komorbidite) - Hastane altyapÄ±sÄ± - Uzun dÃ¶nem takip imkanlarÄ±</p>

<p><strong>Ã–te yandan</strong> bazÄ± uzmanlar omega gastrik bypass'ta uzun dÃ¶nem safra reflÃ¼ riskinin tam olarak deÄŸerlendirilemediÄŸini belirtiyor. Bu konuda daha uzun takip sÃ¼reli Ã§alÄ±ÅŸmalara ihtiyaÃ§ var.</p>

<h2>Gelecek Perspektifi</h2>

<h3>Devam Eden AraÅŸtÄ±rmalar</h3>

<p><strong>ğŸ”´ Erken kanÄ±t</strong> Pilot Ã§alÄ±ÅŸmalar: - 5 yÄ±llÄ±k uzun dÃ¶nem takip verileri bekleniyor - Revision cerrahisi ihtiyacÄ± oranlarÄ± - YaÅŸam kalitesi Ã¶lÃ§Ã¼mleri</p>

<h3>Teknolojik GeliÅŸmeler</h3>

<ul>
<li>Robotik cerrahi uygulamalarÄ± artÄ±yor</li>
<li>Laparoskopik teknikler geliÅŸiyor</li>
<li>AI destekli hasta seÃ§imi algoritmalarÄ± test ediliyor</li>
</ul>

<h2>SonuÃ§ ve Ã–neriler</h2>

<p>YOMEGA Ã§alÄ±ÅŸmasÄ±, omega gastrik bypass'Ä±n Roux-en-Y gastrik bypass'a eÅŸdeÄŸer etkinlik ve gÃ¼venlik profili gÃ¶sterdiÄŸini ortaya koyuyor. <strong>ğŸŸ¢ GÃ¼Ã§lÃ¼ kanÄ±t</strong> Her iki teknik de obez hastalarda anlamlÄ± kilo kaybÄ± ve metabolik iyileÅŸme saÄŸlÄ±yor.</p>

<p><strong>Pratik Ã¶neriler:</strong> 1. Her iki teknik de etkili seÃ§enek 2. CerrahÄ±n deneyimi en Ã¶nemli faktÃ¶r 3. Hasta Ã¶zelikleri gÃ¶z Ã¶nÃ¼nde bulundurulmalÄ± 4. Uzun dÃ¶nem takip ÅŸart 5. Multidisipliner yaklaÅŸÄ±m gerekli</p>

<p><strong>UnutmayÄ±n:</strong> Bariatrik cerrahi sadece bir araÃ§. BaÅŸarÄ±, yaÅŸam tarzÄ± deÄŸiÅŸikliÄŸi ve uzun dÃ¶nem takiple mÃ¼mkÃ¼n. Hangi tekniÄŸin size uygun olduÄŸunu deneyimli bir bariatrik cerrahi uzmanÄ±yla gÃ¶rÃ¼ÅŸerek belirlemelisiniz.</p>
        </div>

        <div class="key-points">
            <h4>ğŸ“Œ Ã–nemli Noktalar</h4>
            <ul><li>YOMEGA Ã§alÄ±ÅŸmasÄ± omega gastrik bypass'Ä±n Roux-en-Y'ye eÅŸdeÄŸer etkinlik gÃ¶sterdiÄŸini ortaya koydu</li>
<li>Her iki teknik de %70+ fazla kilo kaybÄ± ve benzer metabolik iyileÅŸme saÄŸlÄ±yor</li>
<li>GÃ¼venlik profilleri karÅŸÄ±laÅŸtÄ±rÄ±labilir, majÃ¶r komplikasyon oranÄ± %2-2.4 arasÄ±</li>
<li>Teknik seÃ§imi cerrahÄ±n deneyimi ve hasta Ã¶zelliklerine gÃ¶re yapÄ±lmalÄ±</li></ul>
        </div>

        <div class="disclaimer">
            âš ï¸ <strong>Ã–nemli:</strong> Bu iÃ§erik sadece bilgilendirme amaÃ§lÄ±dÄ±r ve tÄ±bbi tavsiye yerine geÃ§mez. Herhangi bir tedaviye baÅŸlamadan Ã¶nce mutlaka doktorunuza danÄ±ÅŸÄ±n.
        </div>

        <div class="sources">
            <h4>ğŸ“š Kaynaklar</h4>
            <ul><li><a href="https://doi.org/10.1016/S0140-6736(19)30475-1" target="_blank" rel="noopener">Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393(10178):1299-1309.</a></li>
<li><a href="https://doi.org/10.1007/s11695-023-07019-4" target="_blank" rel="noopener">Parmar CD, Bryant C, Luque-de-Leon E, et al. Roux-en-Y versus one-anastomosis gastric bypass (RYSA study): weight loss, metabolic improvements, and nutrition at 1 year after surgery, a multicenter randomized controlled trial. Obes Surg. 2024;34(3):721-732.</a></li>
<li><a href="https://doi.org/10.1016/j.soard.2022.06.010" target="_blank" rel="noopener">Chevallier JM, Arman GA, Guenzi M, et al. One Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass: 5-year outcomes of a multicenter randomized trial. Surg Obes Relat Dis. 2022;18(10):1207-1214.</a></li>
<li><a href="https://doi.org/10.1001/jama.2017.20313" target="_blank" rel="noopener">Salminen P, HelmiÃ¶ M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241-254.</a></li>
<li><a href="https://doi.org/10.1007/s11695-018-3593-1" target="_blank" rel="noopener">Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782-795.</a></li></ul>
        </div>

        <div class="share-section">
            <p><strong>Bu yazÄ±yÄ± paylaÅŸÄ±n</strong></p>
            <div class="share-buttons">
                <a href="https://twitter.com/intent/tweet?text=Omega%20Gastrik%20Bypass%20vs%20Roux-en-Y%3A%20Hangisi%20Daha%20Etkili%3F%20%7C%20UzunYa%C5%9Fa&url=https%3A%2F%2Fuzunyasa.com%2Fpages%2Fblog%2Fomega-gastrik-bypass-vs-rouxeny-hangisi-daha-etkili.html" class="share-btn twitter" target="_blank" rel="noopener">Twitter</a>
                <a href="https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fuzunyasa.com%2Fpages%2Fblog%2Fomega-gastrik-bypass-vs-rouxeny-hangisi-daha-etkili.html" class="share-btn linkedin" target="_blank" rel="noopener">LinkedIn</a>
                <a href="https://wa.me/?text=Omega%20Gastrik%20Bypass%20vs%20Roux-en-Y%3A%20Hangisi%20Daha%20Etkili%3F%20https%3A%2F%2Fuzunyasa.com%2Fpages%2Fblog%2Fomega-gastrik-bypass-vs-rouxeny-hangisi-daha-etkili.html" class="share-btn whatsapp" target="_blank" rel="noopener">WhatsApp</a>
            </div>
        </div>

        <div class="cta-section">
            <h3>SaÄŸlÄ±ÄŸÄ±nÄ±zÄ± test edin</h3>
            <p>2 dakikada kiÅŸisel saÄŸlÄ±k deÄŸerlendirmenizi yapÄ±n</p>
            <a href="../test.html" class="cta-btn">Teste BaÅŸla â†’</a>
        </div>
    </article>

    <footer><p>Â© 2026 UzunYaÅŸa. TÃ¼m haklarÄ± saklÄ±dÄ±r.</p></footer>
</body>
</html>